Menin-MLL
Menin-MLL interaction is a drug target for leukemia treatment. Menin is a multiple endocrine neoplasia (MEN1) products which interacts with MLL (mixed lineage leukemia) in a histone methyltransferase complex.
- Cat.No. Product Name Information
-
B6166
MI-136
menin-MLL interaction inhibitor
-
A3602
MI-2
Menin-MLL Inhibitor
-
C3326
MI-2 (hydrochloride)
menin-MLL interaction inhibitor
-
A3603
MI-3
Menin-MLL Inhibitor
-
C3379
MI-nc (hydrochloride)
weak inhibitor of menin-MLL interaction